To find out more about Beachside Recovery Center substance abuse treatment services, please contact us by phone or email..
Barbiturates are older sedatives largely displaced by benzodiazepines, though they remain in use for seizure disorders, some anesthesia and certain headache preparations. They are worth understanding because they carry the narrowest safety margin of any sedative class: the gap between a dose that sedates and a dose that stops breathing is small, and it narrows further as tolerance builds.
Beachside Behavioral Health is a licensed drug and alcohol treatment provider on the Orange County coast, with our corporate office in Newport Beach. We provide medically supervised detox, residential inpatient treatment, intensive outpatient care, outpatient care and dual diagnosis treatment for co-occurring mental health conditions.
We keep client intake deliberately low so every person gets individual attention. Call (888) 387-5576 for a confidential assessment, or send us a message. An assessment is free and carries no obligation.
Benzodiazepines enhance the effect of the brain’s own GABA. Barbiturates go further and can open the same chloride channels directly, without GABA present. That difference sounds technical and is the whole safety story: benzodiazepine effect has a natural ceiling, and barbiturate effect does not.
The dangerous part is that tolerance to the sedative effect builds faster than tolerance to the respiratory effect. A person takes more to get the same calm, while the dose that would suppress their breathing barely moves. The two figures converge, and eventually a dose that produces the desired effect is also close to a dose that is fatal. Adding alcohol or an opioid collapses the margin entirely.
Butalbital deserves particular attention. People take it for migraines, use escalates as rebound headaches set in, and dependence develops without anything that looks like drug seeking. The headaches then become both the reason to take it and a symptom of taking it.
This is not a milder version of a benzodiazepine problem. Barbiturate withdrawal is at least as dangerous and often more so, and unsupervised withdrawal from significant dependence can be fatal.
Symptoms typically begin within eight to sixteen hours for shorter acting agents, and later for long acting ones. Anxiety, tremor, insomnia, nausea and vomiting, weakness, rapid heart rate and blood pressure instability come first. Grand mal seizures and a delirium closely resembling delirium tremens can follow, with confusion, hallucinations, agitation, fever and dangerous cardiovascular instability.
The clinical approach is inpatient medical management with a controlled, slow taper, often converting to a long acting barbiturate such as phenobarbital and reducing gradually, with continuous monitoring. This is not a taper to attempt at home, and it is not something to combine with a plan to simply push through.
Treatment begins with medically supervised detox, and given the seizure and delirium risk this is one of the clearest indications for inpatient care in all of addiction medicine. Evaluation comes first, because the taper depends on which agent, what dose, how long, and what else is on board.
After stabilization the question is what the barbiturate was being used for. Chronic headache, insomnia, an anxiety disorder or a seizure condition each require an actual answer, or the person is simply left with the original problem and no way to manage it. That may mean a headache specialist, cognitive behavioral therapy for insomnia, or integrated treatment for a co-occurring condition. Residential treatment gives time for both the physiological and the practical parts of that to be worked out.
Yes, though far less than they once were. Phenobarbital remains important in seizure medicine, and butalbital combinations are still prescribed for headaches. Most current dependence originates with a legitimate prescription rather than illicit use.
Similar effects, considerably less safety margin. Both can produce dangerous withdrawal. Barbiturate overdose is more likely to be fatal at doses closer to those a dependent person is already taking, and there is no reversal agent comparable to what exists for opioids.
Talk to a clinician first. Daily or near daily use produces genuine physical dependence, withdrawal can include seizures, and rebound headache makes unsupervised attempts unpleasant enough that most people give up. A supervised taper alongside a proper headache plan works considerably better.
No. Naloxone reverses opioids only. If you are unsure what someone has taken, give naloxone anyway, because opioids may be involved and it does no harm if they are not, then call 911 and stay with them.
Back to all Addiction Resources
Need help now? In an emergency call 911. If you are in crisis or thinking about suicide, call or text 988 to reach the Suicide and Crisis Lifeline (veterans press 1). For free, confidential treatment referrals 24 hours a day, call the SAMHSA National Helpline at 1-800-662-4357. You can also search licensed programs at FindTreatment.gov.
This page provides general health education. It is not medical advice, a diagnosis, or a treatment plan. Never stop or change a prescribed medication without speaking to a clinician first. Withdrawal from alcohol, benzodiazepines and barbiturates can cause seizures and can be fatal without medical supervision.